中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Menu
Issue 3
Mar.  2017
Turn off MathJax
Article Contents
Abstract
References
Article Navigation >  Journal of Clinical Hepatology  > 2017  >  33(3): 502-506

Clinical features of elderly patients with drug-induced liver injury

DOI: 10.3969/j.issn.1001-5256.2017.03.021

  • Department of Gastroenterology, Dalian Municipal Central Hospital

Research funding:

 

  • Published Date: 2017-03-20
    Abstract

  • Objective To investigate the clinical features of elderly patients with drug-induced liver injury (DILI) .Methods A retrospective analysis was performed for the clinical data of elderly and young and middle-aged patients with DILI who were hospitalized in Dalian Municipal Central Hospital and The First Affiliated Hospital of Dalian Medical University from January 2010 to December 2015, including sex, age, underlying diseases, drugs causing liver injury, main clinical manifestations, liver function parameters [serum levels of alanine aminotransferase (ALT) , aspartate aminotransferase, alkaline phosphatase (ALP) , gamma-glutamyl transpeptidase (GGT) , albumin, total bilirubin (TBil) , and direct bilirubin (DBil) ], clinical type, treatment, and prognosis.The chi-square test was used for comparison of categorical data between groups, and the Kolmogorov-Smirnov Z test was used for comparison of continuous data between groups.Results Among the 350 patients with DILI, there were 98 elderly patients (elderly group) .The three most common underlying diseases in the elderly group were cerebrovascular and cardiovascular diseases (31.6%) , osteoarthropathy (26.5%) , and malignant tumor (18.4%) , and the elderly group had significantly higher proportions of patients with these diseases than the young and middle-aged group (31.6%/26.5%/18.4% vs 5.6%/6.3%/4.8%, χ2=42.825, 27.214, and 16.667, all P<0.001) .Among the drugs causing liver injury, traditional Chinese medicine was applied most frequently in the elderly group and the young and middle-aged group (53.1% and44.4%, respectively) , and the elderly group had significantly higher proportions of patients using cardiovascular drugs or antitumor drugs than the young and middle-aged group (26.5%/9.2% vs 4.0%/3.2%, χ2=38.925 and 5.513, P<0.001 and P=0.026) .The elderly group had significantly higher proportions of patients with jaundice (53.1%) or pruritus (22.4%) than the young and middle-aged group (40.5%, 7.1%) (χ2=4.536 and 16.331, P=0.041 and P<0.001) .The most common clinical type in both groups was hepatocellular injury type;compared with the young and middle-aged group, the elderly group had a significantly lower proportion of hepatocellular injury type cases (60.2% vs 81.7%, χ2=17.807, P<0.001) and a significantly higher proportion of cholestasis type cases (28.6% vs 7.9%, χ2=25.389, P<0.001) .Compared with the young and middle-aged group, the elderly group had significantly lower levels of ALT and ALP and significantly higher levels of GGT, TBil, and DBil (Z=-3.141, -2.599, -7.449, -10.277, and-9.278, all P<0.01) .Three patients in the elderly group and one in the young and middle-aged group died during hospitalization.Conclusion Underlying diseases and drugs causing liver injury in elderly patients with DILI are different from those in young and middle-aged patients, and the elderly patients have a higher proportion of cholestasis type cases compared with the young and middle-aged patients.Therefore, prevention and treatment of DILI in elderly patients should be taken seriously.

     

    • FullText(HTML)
    • References(14)
  • [1]LU RJ, ZHANG Y, TANG FL, et al.Clinical characteristics of drug-induced liver injury and related risk factors[J].Exp Ther Med, 2016, 12 (4) :2606-2616.
    [2]LEE BM, LEE WC, JANG JY, et al.Clinical features of drug-induced liver injury according to etiology[J].J Korean Med Sci, 2015, 30 (12) :1815-1820.
    [3]ZHANG Y, ZHANG GS, BAO ZJ, et al.Controlled clinical studies on drug-induced liver injury in the elderly Chinese patients:a literature review[J].Clin J Gen Pract, 2013, 12 (11) :890-893. (in Chinese) 张颖, 张赣生, 保志军, 等.国内老年人药物性肝损伤的临床对照研究文献分析[J].中华全科医师杂志, 2013, 12 (11) :890-893.
    [4]MITCHELL SJ, HILMER SN.Drug-induced liver injury in older adults[J].Ther Adv Drug Saf, 2010, 1 (2) :65-77.
    [5]Drug-induced Liver Disease Study Group, Chinese Society of Hepatology.Guidelines for the management of drug-induced liver injury[J].J Clin Hepatol, 2015, 31 (11) :1752-1769. (in Chinese) 中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南[J].临床肝胆病杂志, 2015, 31 (11) :1752-1769.
    [6]STINE JG, SATEESH P, LEWIS JH.Drug-induced liver injury in the elderly[J].Curr Gastroenterol Rep, 2013, 15 (1) :299.
    [7]LIN JY, ZHANG Y.Clinical features and pathogenesis of drug-induced liver injury in the elderly[J].Chin J Gerontol 2013, 33 (16) :4098-4101. (in Chinese) 林佳瑶, 张玉.老年人药物性肝损伤的临床特点及发病机制[J].中国老年学杂志, 2013, 33 (16) :4098-4101.
    [8]PANG LL, YANG WN, HOU FQ.Clinical manifestations of elderly and non-elderly patients with drug induced liver injury[J].AD-RJ, 2016, 18 (3) :163-169. (in Chinese) 逄丽丽, 杨婉娜, 侯凤琴.老年与非老年药物性肝损伤患者的临床特征[J].药物不良反应杂志, 2016, 18 (3) :163-169.
    [9]DUAN XF, ZHANG YJ, QIAN F, et al.Analysis of etiology and clinical features of acute drug-induced liver injury in the elderly[J/CD].Chin J Clinicians:Electronic Edition, 2012, 6 (14) :3972-3975. (in Chinese) 段雪飞, 张亦瑾, 钱芳, 等.老年人急性药物性肝损伤的病因及临床特点分析[J].中华临床医师杂志:电子版, 2012, 6 (14) :3972-3975.
    [10]RASCHI E, de PONTI F.Drug-and herb-induced liver injury:Progress, current challenges and emerging signals of post-marketing risk[J].World J Hepatol, 2015, 7 (13) :1761-1771.
    [11]LIU LN, CHEN W, GUO HY, et al.Comparative study on clinical characteristics of 78 cases with drug-induced liver injury caused by Traditional Chinese Medicine or Western medicine[J/CD].Chin JLiver Dis:Electronic Edition, 2015, 7 (1) :46-50. (in Chinese) 刘丽娜, 陈婉, 郭海燕, 等.78例中药与西药引发药物性肝损伤的临床特性研究[J/CD].中国肝脏病杂志:电子版, 2015, 7 (1) :46-50.
    [12]WANG YZ, ZHANG Y.Clinical features of drug-induced liver injury in the elderly:a review of Chinese literatures 2006-2011[J].Chin J Gastroenterol Hepatol, 2012, 21 (5) :473-476. (in Chinese) 王悦之, 张玉.2006年-2011年国内老年药物性肝损伤的临床特点[J].胃肠病学和肝病学杂志, 2012, 21 (5) :473-476.
    [13]CHALASANI N, BONKOVSKY HL, FONTANA R, et al.Features and outcomes of 899 patients with drug-induced liver injury:the dilin prospective study[J].Gastroenterology, 2015, 148 (7) :1340-1352.e7.
    [14]TESCHKE R, DANAN G.Diagnosis and management of drug-induced liver injury (DILI) in patients with pre-existing liver disease[J].Drug Saf, 2016, 39 (8) :729-744.
    • Relative Articles

  • Relative Articles

    [1]Qian XUE, Chunling JIA, Jingtong WANG. Association between nonalcoholic fatty liver disease and osteoporosis in elderly patients[J]. Journal of Clinical Hepatology, 2024, 40(8): 1585-1590. doi: 10.12449/JCH240813
    [2]Tingting HE, Qingsheng LIANG, Liping WANG, Longxin LIANG, Xiaohan LI, Yanfei CUI, Jing JING, Zhaofang BAI, Man GONG, Ruilin WANG. Diagnostic values of integrated evidence chain, Roussel Uclaf Causality Assessment Method, and Structured Expert Opinion Process method for drug-induced liver injury[J]. Journal of Clinical Hepatology, 2022, 38(1): 141-147. doi: 10.3969/j.issn.1001-5256.2022.01.022
    [3]Jin XU, Xin JIANG, Yongfeng YAN, Rui ZHONG, Yan PENG, Xiaowei TANG, Chuankang TANG. Clinical features of elderly patients with acute pancreatitis aged ≥80 years[J]. Journal of Clinical Hepatology, 2021, 37(1): 142-146. doi: 10.3969/j.issn.1001-5256.2021.01.028
    [4]Jing Jing, He TingTing, Wang RuiLin, Zhang Fan, Niu Ming, Guo YuMing, Zhu Yun, Xiao XiaoHe, Wang JiaBo. Detection of the risk signals of drug-induced liver injury: Challenges and advances[J]. Journal of Clinical Hepatology, 2020, 36(3): 491-496. doi: 10.3969/j.issn.1001-5256.2020.03.002
    [5]Wang LiPing, He TingTing, Cui YanFei, Wang ZhongXia, Jing Jing, Wang LiFu, Zhu Yun, Sun YongQiang, Xu WenTao, Yu SiMiao, Sang XiuXiu, Tian Miao, Ren YueBo, Wang RuiLin. Clinical features and changing trend of elderly patients with drug-induced liver injury in The Fifth Medical Center of Chinese PLA General Hospital from 2009 to 2019[J]. Journal of Clinical Hepatology, 2020, 36(10): 2248-2252. doi: 10.3969/j.issn.1001-5256.2020.10.017
    [6]Huang Ang, Sun Ying, Zou ZhengSheng. Recent research advances in chronicity of drug-induced liver injury[J]. Journal of Clinical Hepatology, 2020, 36(3): 501-504. doi: 10.3969/j.issn.1001-5256.2020.03.004
    [7]Xiao XiaoHe. Combination of medicine and pharmacy assists for precise prevention and control of drug-induced liver injury[J]. Journal of Clinical Hepatology, 2020, 36(3): 489-490. doi: 10.3969/j.issn.1001-5256.2020.03.001
    [8]Yang Xue, Tu RongFang, Yang JinHui. Research advances in drug-induced liver injury[J]. Journal of Clinical Hepatology, 2020, 36(3): 509-513. doi: 10.3969/j.issn.1001-5256.2020.03.006
    [9]Zhang YanFang, Guo YuMing, Niu Ming, Ge FeiLin, Jing Jing, Zhu Yun, Zhu ShiShu, Han ZiXin, Wang JiaBo, Liu ShiJing, Xiao XiaoHe. Drug-induced liver injury in children:An analysis of medication and clinical features[J]. Journal of Clinical Hepatology, 2019, 35(3): 579-584. doi: 10.3969/j.issn.1001-5256.2019.03.025
    [10]Ye LiHong, Wang ChongKui, Jin Peng, Zhao LiangLiang, Zhang HaiCong, Liu ZhiQuan, Tang YaFang. Clinicopathological features of drug-induced liver injury or primary biliary cholangitis with vanishing bile duct syndrome[J]. Journal of Clinical Hepatology, 2019, 35(2): 359-363. doi: 10.3969/j.issn.1001-5256.2019.02.023
    [11]Yan Rong, Song ZhengJun. Clinical features and prognosis of drug-induced liver injury: An analysis of 95 cases[J]. Journal of Clinical Hepatology, 2018, 34(6): 1242-1247. doi: 10.3969/j.issn.1001-5256.2018.06.022
    [12]Yu LeCheng, Fan Ye, Chen ChengWei. Diagnosis and treatment of drug-induced liver injury[J]. Journal of Clinical Hepatology, 2018, 34(6): 1160-1165. doi: 10.3969/j.issn.1001-5256.2018.06.004
    [13]Chou LiXia, Fan ZuoPeng, Liu Ying, Liang Shan, Nie Wei, Lin Wei, Liu YiRong, Zhang Jing, Hu ZhongJie. Application of a modified diagnostic scale in diagnosis of acute drug-induced liver injury[J]. Journal of Clinical Hepatology, 2017, 33(7): 1328-1331. doi: 10.3969/j.issn.1001-5256.2017.07.025
    [14]Zhang Dong, Zhang Tao, Wu YuNan, Sun KeWei. A systematic analysis of the application of diagnostic criteria for drug-induced liver injury in China based on the literature[J]. Journal of Clinical Hepatology, 2017, 33(5): 919-923. doi: 10.3969/j.issn.1001-5256.2017.05.026
    [15]Yuan Ling, Yang YongGeng, Shen YouXiu, Ma YingCai. Research advances in drug- induced liver injury[J]. Journal of Clinical Hepatology, 2017, 33(2): 375-378. doi: 10.3969/j.issn.1001-5256.2017.02.038
    [16]Fan ZuoPeng, Liang Shan, Nie Wei, Chou LiXia, Chen Jie, Zhang Jing, Jin RongHua, Hu ZhongJie. Application of drug lymphocyte stimulation test using cell counting kit-8 assay in diagnosis of acute drug-induced liver injury[J]. Journal of Clinical Hepatology, 2016, 32(8): 1562-1565. doi: 10.3969/j.issn.1001-5256.2016.08.026
    [17]Yu YueCheng, Fan Ye. Advances in Roussel Uclaf Causality Assessment Method for diagnosis of drug-induced liver injury and its comparison with structured expert opinion process[J]. Journal of Clinical Hepatology, 2016, 32(9): 1706-1713. doi: 10.3969/j.issn.1001-5256.2016.09.014
    [18]Gan Yu, Dong Yi, Zhang HongFei, Xu ZhiQiang, Chen DaWei, Wang LiMin, Wang FuChuan, Yan JianGuo, Zhu ShiShu. Clinical characteristics and outcomes of drug-induced liver injury in children: a study of 184 cases[J]. Journal of Clinical Hepatology, 2015, 31(8): 1244-1247. doi: 10.3969/j.issn.1001-5256.2015.08.015
    [19]Lu Yi, Yu Hui. Discussion on idiosyncratic drug-induced liver injury in children[J]. Journal of Clinical Hepatology, 2015, 31(8): 1215-1217. doi: 10.3969/j.issn.1001-5256.2015.08.008
    [20]Zhou XianShan, Hong HuiLan. Clinical analysis of elderly patients with chronic hepatitis C[J]. Journal of Clinical Hepatology, 2008, 24(5): 364-366.
    • Supplements(0)
    • Cited By

  • Cited by

    Periodical cited type(9)

    1. 贾茜，张厚莉，卓龙冉，王海敏，邱妮娜，苏凤云. 基于RUCAM分析药物性肝损伤181例的风险因素及临床用药特点. 临床合理用药. 2024(21): 156-159 .
    2. 郑晓倩，苏建花，宣伟东，丁叶，周忠敏，闫玉婷，祝纯蕙. 美罗培南致肝损伤1例并文献分析. 临床合理用药. 2024(30): 174-177 .
    3. 张艳芳，叶旭军，陈敏，王桦. 头孢曲松/他唑巴坦致急性肝损伤1例. 药物流行病学杂志. 2021(06): 421-422 .
    4. 栗啸阳，郭代红，孔祥豪，刘思源，杨鸿溢，姚翀. 头孢哌酮钠/舒巴坦钠相关肝损伤的自动监测研究. 药物流行病学杂志. 2020(09): 606-609 .
    5. 杨雯，王琦. 我院371例药物性肝损伤的临床特征及预后分析. 中国药物警戒. 2019(05): 293-296+300 .
    6. 张方宇，李丽. 益肝灵片联合还原型谷胱甘肽治疗老年患者药物性肝损伤的疗效观察. 湖南师范大学学报(医学版). 2019(04): 161-163 .
    7. 林云霞，何晓彬. 药物性肝损伤的临床特点及危险因素分析. 临床肝胆病杂志. 2018(06): 1237-1241 . 本站查看
    8. 徐佳，黄琪，杨志玲. 我院区2016年利奈唑胺临床应用合理性评价. 中国临床药理学与治疗学. 2018(01): 110-115 .
    9. 付锋，任占卫. 慢性丙肝后肝硬化患者T淋巴细胞亚群检测对肝细胞损伤的预测价值. 现代消化及介入诊疗. 2017(05): 683-685 .

    Other cited types(3)

  • Created with Highcharts 5.0.7Amount of accessChart context menuAbstract Views, HTML Views, PDF Downloads StatisticsAbstract ViewsHTML ViewsPDF Downloads2024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-032025-04010203040
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 2.7 %FULLTEXT: 2.7 %META: 92.7 %META: 92.7 %PDF: 4.6 %PDF: 4.6 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 8.7 %其他: 8.7 %其他: 0.4 %其他: 0.4 %Canton: 0.5 %Canton: 0.5 %Howard: 0.5 %Howard: 0.5 %India: 0.4 %India: 0.4 %Lewisburg: 0.2 %Lewisburg: 0.2 %Norman: 0.2 %Norman: 0.2 %Rochester: 0.4 %Rochester: 0.4 %United States: 0.4 %United States: 0.4 %上海: 2.4 %上海: 2.4 %凤凰城: 0.2 %凤凰城: 0.2 %北京: 4.9 %北京: 4.9 %南宁: 0.5 %南宁: 0.5 %卡罗尔顿: 0.2 %卡罗尔顿: 0.2 %台州: 1.8 %台州: 1.8 %吉林: 0.7 %吉林: 0.7 %哥伦布: 0.2 %哥伦布: 0.2 %圣保罗: 0.2 %圣保罗: 0.2 %埃文斯维尔: 0.2 %埃文斯维尔: 0.2 %天津: 0.9 %天津: 0.9 %奥兰多: 0.2 %奥兰多: 0.2 %安條克: 0.4 %安條克: 0.4 %布雷登顿: 0.4 %布雷登顿: 0.4 %张家口: 4.2 %张家口: 4.2 %成都: 0.4 %成都: 0.4 %昆明: 0.2 %昆明: 0.2 %本德: 0.2 %本德: 0.2 %杭州: 1.1 %杭州: 1.1 %沃思堡: 0.7 %沃思堡: 0.7 %沈阳: 0.2 %沈阳: 0.2 %济南: 0.2 %济南: 0.2 %海得拉巴: 0.2 %海得拉巴: 0.2 %温州: 0.2 %温州: 0.2 %湖州: 1.5 %湖州: 1.5 %福州: 0.4 %福州: 0.4 %科珀斯克里斯蒂: 0.2 %科珀斯克里斯蒂: 0.2 %秦皇岛: 0.2 %秦皇岛: 0.2 %纽卡斯尔: 0.2 %纽卡斯尔: 0.2 %纽敦: 0.2 %纽敦: 0.2 %纽瓦克: 0.2 %纽瓦克: 0.2 %纽约: 0.2 %纽约: 0.2 %芒廷维尤: 32.8 %芒廷维尤: 32.8 %芝加哥: 0.9 %芝加哥: 0.9 %苏州: 0.4 %苏州: 0.4 %莫斯科: 2.0 %莫斯科: 2.0 %衢州: 1.5 %衢州: 1.5 %西宁: 25.1 %西宁: 25.1 %费城: 0.2 %费城: 0.2 %金华: 0.4 %金华: 0.4 %银川: 0.4 %银川: 0.4 %长春: 0.5 %长春: 0.5 %长沙: 0.4 %长沙: 0.4 %长治: 0.2 %长治: 0.2 %青岛: 0.2 %青岛: 0.2 %其他其他CantonHowardIndiaLewisburgNormanRochesterUnited States上海凤凰城北京南宁卡罗尔顿台州吉林哥伦布圣保罗埃文斯维尔天津奥兰多安條克布雷登顿张家口成都昆明本德杭州沃思堡沈阳济南海得拉巴温州湖州福州科珀斯克里斯蒂秦皇岛纽卡斯尔纽敦纽瓦克纽约芒廷维尤芝加哥苏州莫斯科衢州西宁费城金华银川长春长沙长治青岛

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (2437) PDF downloads(429) Cited by(12)
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[2389]YesterdayPV[5285]TodayIP[2121]TodayPV[4648]Online[48]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return